A comparative study of propofol- Dexmedetomidine versus propofol-ketamine for anesthetic management of patients during Endoscopic Retrograde Cholangiopancreatography (ERCP)
Not Applicable
- Registration Number
- CTRI/2023/05/052890
- Lead Sponsor
- Dr Ipshita Garg
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Asa 2 and Asa 3 fit patients . Patients that are haemodynamically stable and giving written informed consent.
Exclusion Criteria
Procedures less than 20 minutes. Patients refusal . Patients with pre existing cardiovascular diseases. Patients with h/o allergy to test drugs . Patients with neurological disorders and muscle diseases.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Comparison of haemodynamic Stability between Propofol Dexmedetomidine and Propofol Ketamine during ERCP Procedures.Timepoint: Baseline BP. BP Every 5 min of loading dose for 15 minutes. At intubation, then every 10 minutes for entire duration of procedure,at extubation. Then post operatively every 15 minutes for an hour.
- Secondary Outcome Measures
Name Time Method Post op assessment of Vas score sedation score , Vitals and total propofol consumption at the end of the procedure.Timepoint: Every 15 minutes for 1 hour.